References

Costs and causes of oncology drug attrition with the example of insulin-like growth factor-1 receptor inhibitors

10.1001/jamanetworkopen.2023.24977 · ExternalCitation · doi-reference

GWAS advancements to investigate disease associations and biological mechanisms

10.1002/ctd2.296 · ExternalCitation · doi-reference

Genetic heterogeneity: challenges, impacts, and methods through an associative lens

10.1002/gepi.22497 · ExternalCitation · doi-reference

Integrative multi-omics approach for improving causal gene identification

10.1002/gepi.22601 · ExternalCitation · doi-reference

Protein posttranslational modifications in health and diseases: functions, regulatory mechanisms, and therapeutic implications

10.1002/mco2.261 · ExternalCitation · doi-reference

Beyond single biomarkers: multi-omics strategies to predict immunotherapy outcomes in blood cancers

10.1007/s10238-025-01902-w · ExternalCitation · doi-reference

High-throughput computational screening for lead discovery and development

10.1016/bs.apha.2025.01.001 · ExternalCitation · doi-reference

Genomic, transcriptomic and epigenomic analysis towards the understanding of porcine semen quality traits. Past, current and future trends

10.1016/j.anireprosci.2024.107543 · ExternalCitation · doi-reference

Why 90% of clinical drug development fails and how to improve it?

10.1016/j.apsb.2022.02.002 · ExternalCitation · doi-reference

Gene expression and protein abundance: Just how associated are these molecular traits?

10.1016/j.biotechadv.2025.108720 · ExternalCitation · doi-reference

Cryptic binding sites on proteins: definition, detection, and druggability

10.1016/j.cbpa.2018.05.003 · ExternalCitation · doi-reference

The life-saving benefit of dexamethasone in severe COVID-19 is linked to a reversal of monocyte dysregulation

10.1016/j.cell.2024.06.014 · ExternalCitation · doi-reference

Untargeted metabolomic study by liquid chromatography–mass spectrometry in brain tissues on the effects of combined cocaine and ethanol self-administration in male and female young rats

10.1016/j.chroma.2023.464047 · ExternalCitation · doi-reference

Mechanistic and data-driven models of cell signaling: tools for fundamental discovery and rational design of therapy

10.1016/j.coisb.2021.05.010 · ExternalCitation · doi-reference

Biological interacting units identified in human protein networks reveal tissue-functional diversification and its impact on disease

10.1016/j.csbj.2022.07.006 · ExternalCitation · doi-reference

Network-based approaches for modeling disease regulation and progression

10.1016/j.csbj.2022.12.022 · ExternalCitation · doi-reference

Designing RNA sequencing experiments: a practical guide to reproducible gene expression analysis

10.1016/j.csbj.2025.12.015 · ExternalCitation · doi-reference

Machine learning for drug-target interaction prediction: a comprehensive review of models, challenges, and computational strategies

10.1016/j.csbj.2025.12.033 · ExternalCitation · doi-reference

Artificial intelligence in drug discovery and development

10.1016/j.drudis.2020.10.010 · ExternalCitation · doi-reference

DNA methylation in human diseases

10.1016/j.heliyon.2024.e32366 · ExternalCitation · doi-reference

A comprehensive review of feature based methods for drug target interaction prediction

10.1016/j.jbi.2019.103159 · ExternalCitation · doi-reference

Computational frameworks integrating deep learning and statistical models in mining multimodal omics data

10.1016/j.jbi.2024.104629 · ExternalCitation · doi-reference

CellEKT: a robust chemical proteomics workflow to profile cellular target engagement of kinase inhibitors

10.1016/j.mcpro.2025.100961 · ExternalCitation · doi-reference

Challenges and opportunities in the network medicine of complex diseases

10.1016/j.medj.2025.100920 · ExternalCitation · doi-reference

Use and misuse of corrections for multiple testing

10.1016/j.metip.2023.100120 · ExternalCitation · doi-reference

Targeting pathological ERK1/2 signaling in cancer and beyond

10.1016/j.molmed.2025.08.001 · ExternalCitation · doi-reference

Bioinformatics models in drug delivery: predicting biomaterial-biological interactions for targeted therapies

10.1016/j.nxnano.2025.100335 · ExternalCitation · doi-reference

Affinity measurement of strong ligands with NMR spectroscopy: limitations and ways to overcome them

10.1016/j.pnmrs.2023.07.001 · ExternalCitation · doi-reference

Dynamics-based drug discovery by time-resolved cryo-EM

10.1016/j.sbi.2025.103001 · ExternalCitation · doi-reference

Perspectives on phenotypic screening−screen design and assay technology special interest group

10.1016/j.slasd.2024.02.001 · ExternalCitation · doi-reference

The future of integrated structural biology

10.1016/j.str.2024.08.014 · ExternalCitation · doi-reference

Advancing drug safety in drug development: bridging computational predictions for enhanced toxicity prediction

10.1021/acs.chemrestox.3c00352 · ExternalCitation · doi-reference

Thermodynamics and kinetics of drug-target binding by molecular simulation

10.1021/acs.chemrev.0c00534 · ExternalCitation · doi-reference

1H-Detected Biomolecular NMR under Fast Magic-Angle Spinning

10.1021/acs.chemrev.1c00918 · ExternalCitation · doi-reference

Synthetic biology in natural product biosynthesis

10.1021/acs.chemrev.4c00567 · ExternalCitation · doi-reference

Graph neural networks in modern AI-aided drug discovery

10.1021/acs.chemrev.5c00461 · ExternalCitation · doi-reference

GROMACS in the cloud: a global supercomputer to speed up alchemical drug design

10.1021/acs.jcim.2c00044 · ExternalCitation · doi-reference

Machine learning-driven multiscale modeling: bridging the scales with a next-generation simulation infrastructure

10.1021/acs.jctc.2c01018 · ExternalCitation · doi-reference

Kinase atlas: druggability analysis of potential allosteric sites in kinases

10.1021/acs.jmedchem.9b00089 · ExternalCitation · doi-reference

Decrypting allostery in membrane-bound K-Ras4B using complementary in silico approaches based on unbiased molecular dynamics simulations

10.1021/jacs.3c11396 · ExternalCitation · doi-reference

Impact of structural biology and the protein data bank on us fda new drug approvals of low molecular weight antineoplastic agents 2019–2023

10.1038/s41388-024-03077-2 · ExternalCitation · doi-reference

Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management

10.1038/s41392-023-01469-6 · ExternalCitation · doi-reference

New insights into protein–protein interaction modulators in drug discovery and therapeutic advance

10.1038/s41392-024-02036-3 · ExternalCitation · doi-reference

Deconstructing synthetic biology across scales: a conceptual approach for training synthetic biologists

10.1038/s41467-024-49626-x · ExternalCitation · doi-reference

The slit diaphragm in Drosophila exhibits a bilayered, fishnet architecture

10.1038/s41467-025-64347-5 · ExternalCitation · doi-reference

Advancing targeted protein degradation for cancer therapy

10.1038/s41568-021-00365-x · ExternalCitation · doi-reference

Phenotypic drug discovery: recent successes, lessons learned and new directions

10.1038/s41573-022-00472-w · ExternalCitation · doi-reference

Tracing the evolution of sequencing into the era of genomic medicine

10.1038/s41576-025-00884-5 · ExternalCitation · doi-reference

Context-specific regulation and function of mRNA alternative polyadenylation

10.1038/s41580-022-00507-5 · ExternalCitation · doi-reference

Ångström-resolution fluorescence microscopy

10.1038/s41586-023-05925-9 · ExternalCitation · doi-reference

Advancing human genetics research and drug discovery through exome sequencing of the UK Biobank

10.1038/s41588-021-00885-0 · ExternalCitation · doi-reference

Chemical proteomics reveals the target landscape of 1,000 kinase inhibitors

10.1038/s41589-023-01459-3 · ExternalCitation · doi-reference

Evaluation of connectivity map shows limited reproducibility in drug repositioning

10.1038/s41598-021-97005-z · ExternalCitation · doi-reference

Graph neural network-based drug-drug interaction prediction

10.1038/s41598-025-12936-1 · ExternalCitation · doi-reference

Circulating tumor DNA to monitor treatment response in solid tumors and advance precision oncology

10.1038/s41698-025-00876-y · ExternalCitation · doi-reference

Epigenetic regulators in cancer therapy and progression

10.1038/s41698-025-01003-7 · ExternalCitation · doi-reference

The current role and evolution of X-ray crystallography in drug discovery and development

10.1080/17460441.2023.2246881 · ExternalCitation · doi-reference

Enhancing structural insights for advanced drug discovery by mitigating protein crystal damage

10.1080/17460441.2025.2605354 · ExternalCitation · doi-reference

Revisiting the genome-wide significance threshold for common variant GWAS

10.1093/g3journal/jkaa056 · ExternalCitation · doi-reference

An introduction to types of quasi-experimental designs

10.1097/01.naj.0001081740.74815.20 · ExternalCitation · doi-reference

10.1101/2025.09.04.674143

10.1101/2025.09.04.674143 · ExternalCitation · doi-reference

10.1101/2025.10.13.682238

10.1101/2025.10.13.682238 · ExternalCitation · doi-reference

AlphaFold and the future of structural biology

10.1107/s2052252523004943 · ExternalCitation · doi-reference

A recent update on small-molecule kinase inhibitors for targeted cancer therapy and their therapeutic insights from mass spectrometry-based proteomic analysis

10.1111/febs.16442 · ExternalCitation · doi-reference

Genome-wide association studies: utility and limitations for research in physiology

10.1113/jp284241 · ExternalCitation · doi-reference

Genetic mutations and epigenetic modifications: driving cancer and informing precision medicine

10.1155/2017/9620870 · ExternalCitation · doi-reference

Comparative analysis of cross-validation techniques: LOOCV, K-folds cross-validation, and repeated K-folds cross-validation in machine learning models

10.11648/j.ajtas.20241305.13 · ExternalCitation · doi-reference

Multi-omics data integration, interpretation, and its application

10.1177/1177932219899051 · ExternalCitation · doi-reference

Pharmacogenetic testing for adverse drug reaction prevention: systematic review of economic evaluations and the appraisal of quality matters for clinical practice and implementation

10.1186/s12913-021-07025-8 · ExternalCitation · doi-reference

Accurate prediction of synergistic drug combination using a multi-source information fusion framework

10.1186/s12915-025-02302-y · ExternalCitation · doi-reference

Network-based analyses of multiomics data in biomedicine

10.1186/s13040-025-00452-x · ExternalCitation · doi-reference

PWAS: proteome-wide association study—linking genes and phenotypes by functional variation in proteins

10.1186/s13059-020-02089-x · ExternalCitation · doi-reference

The importance of bottlenecks in protein networks: correlation with gene essentiality and expression dynamics

10.1371/journal.pcbi.0030059 · ExternalCitation · doi-reference

Advances in personalized medicine: translating genomic insights into targeted therapies for cancer treatment

10.21037/atm-25-34 · ExternalCitation · doi-reference

Implementing findable, accessible, interoperable, reusable (FAIR) principles in child and adolescent mental health research: mixed methods approach

10.2196/59113 · ExternalCitation · doi-reference

Advancements in single-cell RNA sequencing and spatial transcriptomics: transforming biomedical research

10.3389/abp.2025.13922 · ExternalCitation · doi-reference

Determination of pleiotropic effect of warfarin in VKORC1 and CYP2C9 genotypes in patients with heart valve replacement

10.3389/fcvm.2022.895169 · ExternalCitation · doi-reference

Integrative computational approaches for discovery and evaluation of lead compound for drug design

10.3389/fddsv.2024.1362456 · ExternalCitation · doi-reference

Advances and trends in omics technology development

10.3389/fmed.2022.911861 · ExternalCitation · doi-reference

Advances in computational drug repurposing, driver genes, and therapeutics in lung adenocarcinoma

10.3390/biom15101373 · ExternalCitation · doi-reference

Revolutionizing personalized medicine: synergy with multi-omics data generation, main hurdles, and future perspectives

10.3390/biomedicines12122750 · ExternalCitation · doi-reference

Biomarker-driven approaches to bone metastases: from molecular mechanisms to clinical applications

10.3390/biomedicines13051160 · ExternalCitation · doi-reference

Kinase inhibitor treatment of patients with advanced cancer results in high tumor drug concentrations and in specific alterations of the tumor phosphoproteome

10.3390/cancers12020330 · ExternalCitation · doi-reference

Integrated network pharmacology approach for drug combination discovery: a multi-cancer case study

10.3390/cancers14082043 · ExternalCitation · doi-reference

Novel targets, novel treatments: the changing landscape of non-small cell lung cancer

10.3390/cancers15102855 · ExternalCitation · doi-reference

Bridging discovery and treatment: cancer biomarker

10.3390/cancers17223720 · ExternalCitation · doi-reference

H3K4me3, H3K9ac, H3K27ac, H3K27me3 and H3K9me3 histone tags suggest distinct regulatory evolution of open and condensed chromatin landmarks

10.3390/cells8091034 · ExternalCitation · doi-reference

Lipidomics—paving the road towards better insight and precision medicine in rare metabolic diseases

10.3390/ijms24021709 · ExternalCitation · doi-reference

Utilizing molecular dynamics simulations, machine learning, Cryo-EM, and NMR spectroscopy to predict and validate protein dynamics

10.3390/ijms25179725 · ExternalCitation · doi-reference

Mathematical modeling and inference of epidermal growth factor-induced mitogen-activated protein kinase cell signaling pathways

10.3390/ijms251810204 · ExternalCitation · doi-reference

AI-driven polypharmacology in small-molecule drug discovery

10.3390/ijms26146996 · ExternalCitation · doi-reference

Biological breakthroughs and drug discovery revolution via cryo-electron microscopy of membrane proteins

10.3390/membranes15120368 · ExternalCitation · doi-reference

The potential role of metabolomics in drug-induced liver injury (DILI) assessment

10.3390/metabo12060564 · ExternalCitation · doi-reference

Merging ligand-based and structure-based methods in drug discovery: an overview of combined virtual screening approaches

10.3390/molecules25204723 · ExternalCitation · doi-reference

Molecular dynamics simulations in drug discovery and pharmaceutical development

10.3390/pr9010071 · ExternalCitation · doi-reference

Multi-omics integration for the design of novel therapies and the identification of novel biomarkers

10.3390/proteomes11040034 · ExternalCitation · doi-reference

Artificial intelligence-driven drug toxicity prediction: advances, challenges, and future directions

10.3390/toxics13070525 · ExternalCitation · doi-reference

The role of pharmacogenomics in advancing personalised medicine: implications for drug efficacy safety and clinical practice integration

10.70749/ijbr.v3i5.1407 · ExternalCitation · doi-reference